D Lyndon1,2, M van den Broek1,2, B Niu3, S Yip4, A Rohr1,2, F Settecase5,2. 1. Neuroradiology Division (D.L., M.v.d.B., A.R., F.S.), Vancouver General Hospital, Vancouver, British Columbia, Canada. 2. Department of Radiology (D.L., M.v.d.B., A.R., F.S.), University of British Columbia, Vancouver, v, Canada. 3. Vancouver Imaging Inc (B.N.), Vancouver, British Columbia, Canada. 4. Department of Neurology (S.Y.), University of British Columbia, Vancouver, British Columbia, Canada. 5. Neuroradiology Division (D.L., M.v.d.B., A.R., F.S.), Vancouver General Hospital, Vancouver, British Columbia, Canada fabio.settecase@vch.ca.
Abstract
BACKGROUND AND PURPOSE: Collateral blood supply is a key determinant of outcome in large-vessel occlusion acute ischemic stroke. Single- and multiphase CTA collateral scoring systems have been described but are subjective and require training. We aimed to test whether the CTP-derived hypoperfusion intensity ratio is associated with CTA collateral status and whether a threshold hypoperfusion intensity ratio exists that predicts poor CTA collaterals. MATERIALS AND METHODS: Imaging and clinical data of consecutive patients with large-vessel occlusion acute ischemic stroke were retrospectively reviewed. Single-phase CTA and multiphase CTA scoring were performed by 2 blinded neuroradiologists using the Tan, Maas, and Calgary/Menon methods. CTP was processed using RApid processing of PerfusIon and Diffusion software (RAPID). Hypoperfusion intensity ratio = ratio of brain volume with time-to-maximum >10 seconds over time-to-maximum >6-second volume. Correlation between the hypoperfusion intensity ratio and CTA collateral scores was calculated using the Pearson correlation. The optimal threshold of the hypoperfusion intensity ratio for predicting poor collaterals was determined using receiver operating characteristic curve analysis. RESULTS: Fifty-two patients with large-vessel occlusion acute ischemic stroke were included. Multiphase CTA collateral scoring showed better interrater agreement (κ = 0.813) than single-phase CTA (Tan, κ = 0.587; Maas, κ = 0.273). The hypoperfusion intensity ratio correlated with CTA collateral scores (multiphase CTA: r = -0.55; 95% CI, -0.67 to -0.40; P ≤ .001). The optimal threshold for predicting poor multiphase CTA collateral status was a hypoperfusion intensity ratio of >0.45 (sensitivity = 78%; specificity = 76%; area under the curve = 0.86). Patients with high hypoperfusion intensity ratio/poor collateral status had lower ASPECTS/larger infarcts, higher NIHSS scores, and larger hypoperfused volumes. CONCLUSIONS: The hypoperfusion intensity ratio is associated with CTA collateral status in patients with large-vessel occlusion acute ischemic stroke. The hypoperfusion intensity ratio is an automated and quantitative alternative to CTA collateral scoring methods for both clinical and future stroke trial settings.
BACKGROUND AND PURPOSE: Collateral blood supply is a key determinant of outcome in large-vessel occlusion acute ischemic stroke. Single- and multiphase CTA collateral scoring systems have been described but are subjective and require training. We aimed to test whether the CTP-derived hypoperfusion intensity ratio is associated with CTA collateral status and whether a threshold hypoperfusion intensity ratio exists that predicts poor CTA collaterals. MATERIALS AND METHODS: Imaging and clinical data of consecutive patients with large-vessel occlusion acute ischemic stroke were retrospectively reviewed. Single-phase CTA and multiphase CTA scoring were performed by 2 blinded neuroradiologists using the Tan, Maas, and Calgary/Menon methods. CTP was processed using RApid processing of PerfusIon and Diffusion software (RAPID). Hypoperfusion intensity ratio = ratio of brain volume with time-to-maximum >10 seconds over time-to-maximum >6-second volume. Correlation between the hypoperfusion intensity ratio and CTA collateral scores was calculated using the Pearson correlation. The optimal threshold of the hypoperfusion intensity ratio for predicting poor collaterals was determined using receiver operating characteristic curve analysis. RESULTS: Fifty-two patients with large-vessel occlusion acute ischemic stroke were included. Multiphase CTA collateral scoring showed better interrater agreement (κ = 0.813) than single-phase CTA (Tan, κ = 0.587; Maas, κ = 0.273). The hypoperfusion intensity ratio correlated with CTA collateral scores (multiphase CTA: r = -0.55; 95% CI, -0.67 to -0.40; P ≤ .001). The optimal threshold for predicting poor multiphase CTA collateral status was a hypoperfusion intensity ratio of >0.45 (sensitivity = 78%; specificity = 76%; area under the curve = 0.86). Patients with high hypoperfusion intensity ratio/poor collateral status had lower ASPECTS/larger infarcts, higher NIHSS scores, and larger hypoperfused volumes. CONCLUSIONS: The hypoperfusion intensity ratio is associated with CTA collateral status in patients with large-vessel occlusion acute ischemic stroke. The hypoperfusion intensity ratio is an automated and quantitative alternative to CTA collateral scoring methods for both clinical and future stroke trial settings.
Authors: Bijoy K Menon; Christopher D d'Esterre; Emmad M Qazi; Mohammed Almekhlafi; Leszek Hahn; Andrew M Demchuk; Mayank Goyal Journal: Radiology Date: 2015-01-29 Impact factor: 11.105
Authors: E M Fanou; J Knight; R I Aviv; S-P Hojjat; S P Symons; L Zhang; M Wintermark Journal: AJNR Am J Neuroradiol Date: 2015-10-15 Impact factor: 3.825
Authors: Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Bijoy K Menon; Emmad Qazi; Vivek Nambiar; Lydia D Foster; Sharon D Yeatts; David Liebeskind; Tudor G Jovin; Mayank Goyal; Michael D Hill; Thomas A Tomsick; Joseph P Broderick; Andrew M Demchuk Journal: Stroke Date: 2015-03-19 Impact factor: 7.914
Authors: Adam de Havenon; Michael Mlynash; May A Kim-Tenser; Maarten G Lansberg; Thalabe Leslie-Mazwi; Soren Christensen; Ryan A McTaggart; Matthew Alexander; Gregory Albers; Joseph Broderick; Michael P Marks; Jeremy J Heit Journal: Stroke Date: 2019-03 Impact factor: 7.914
Authors: I Y L Tan; A M Demchuk; J Hopyan; L Zhang; D Gladstone; K Wong; M Martin; S P Symons; A J Fox; R I Aviv Journal: AJNR Am J Neuroradiol Date: 2009-01-15 Impact factor: 3.825
Authors: O Y Bang; J L Saver; B H Buck; J R Alger; S Starkman; B Ovbiagele; D Kim; R Jahan; G R Duckwiler; S R Yoon; F Viñuela; D S Liebeskind Journal: J Neurol Neurosurg Psychiatry Date: 2007-12-12 Impact factor: 10.154
Authors: David S Liebeskind; Thomas A Tomsick; Lydia D Foster; Sharon D Yeatts; Janice Carrozzella; Andrew M Demchuk; Tudor G Jovin; Pooja Khatri; Ruediger von Kummer; Rebecca M Sugg; Osama O Zaidat; Syed I Hussain; Mayank Goyal; Bijoy K Menon; Firas Al Ali; Bernard Yan; Yuko Y Palesch; Joseph P Broderick Journal: Stroke Date: 2014-01-28 Impact factor: 7.914
Authors: A Potreck; E Scheidecker; C S Weyland; U Neuberger; C Herweh; M A Möhlenbruch; M Chen; S Nagel; M Bendszus; F Seker Journal: AJNR Am J Neuroradiol Date: 2022-06-09 Impact factor: 4.966
Authors: Stanley Hughwa Hung; Sharon Kramer; Emilio Werden; Bruce C V Campbell; Amy Brodtmann Journal: Front Neurol Date: 2022-02-15 Impact factor: 4.003